We could not find any results for:
Make sure your spelling is correct or try broadening your search.
WESTPORT, Conn., March 26, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy...
Filed Pursuant to Rule 424(b)(3) Registration No. 333-275229 PROSPECTUS SUPPLEMENT (to Prospectus dated November 7, 2023) Portage Biotech Inc. 9,631,580 Ordinary Shares...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE...
Filed Pursuant to Rule 424(b)(3) Registration No. 333-275229 PROSPECTUS SUPPLEMENT (to Prospectus dated November 7, 2023) Portage Biotech Inc. 9,631,580 Ordinary Shares...
WESTPORT, Conn., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG) (“Portage” or the “Company”), a clinical-stage immuno-oncology company advancing novel multi-targeted...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES...
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549Form 6-KREPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934For...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.1132 | 25.1499666741 | 0.4501 | 0.8 | 0.45 | 138413 | 0.55413935 | CS |
4 | -0.1489 | -20.9070485819 | 0.7122 | 0.8 | 0.45 | 60150 | 0.55898667 | CS |
12 | -0.9267 | -62.1946308725 | 1.49 | 1.74 | 0.34 | 65774 | 0.66594496 | CS |
26 | -1.7267 | -75.4017467249 | 2.29 | 2.93 | 0.34 | 48506 | 1.0270335 | CS |
52 | -2.0867 | -78.7433962264 | 2.65 | 4.4 | 0.34 | 32455 | 1.54326525 | CS |
156 | -30.4467 | -98.183489197 | 31.01 | 44.9763 | 0.34 | 32676 | 9.68043952 | CS |
260 | -36.9367 | -98.4978666667 | 37.5 | 44.9763 | 0.34 | 32155 | 9.96087937 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions